Effect of Cinnamomum zeylanicum extract on scopolamine-induced cognitive impairment and oxidative stress in rats

Nutritional Neuroscience

Volumn 18, Issue 5, 2015, Pages 210-216

  Jain, Seema ^a   Sangma, Tultul ^a   Shukla, Santosh Kumar ^b   Mediratta, Pramod Kumari ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b HLL LIFECARE LIMITED   (India)

Author keywords

Cinnamomum zeylanicum; Lauraceae; Morris water maze; Oxidative stress; Passive avoidance; Scopolamine

Indexed keywords

CINNAMOMUM ZEYLANICUM EXTRACT; GLUTATHIONE; MALONALDEHYDE; PLANT EXTRACT; SCOPOLAMINE; UNCLASSIFIED DRUG; SCOPOLAMINE BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; EXPERIMENTAL BEHAVIORAL TEST; LATENT PERIOD; LEARNING; LIPID PEROXIDATION; LOCOMOTION; MALE; MASS FRAGMENTOGRAPHY; MEMORY; MEMORY CONSOLIDATION; MORRIS WATER MAZE TEST; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SCOPOLAMINE-INDUCED COGNITIVE DEFECT; ANIMAL; BARK; BRAIN; CHEMICALLY INDUCED; CHEMISTRY; CINNAMOMUM ZEYLANICUM; COGNITION; COGNITION DISORDERS; DOSE RESPONSE; DRUG EFFECTS; MAZE TEST; METABOLISM; ORAL DRUG ADMINISTRATION; WISTAR RAT;

ANIMALIA; CINNAMOMUM VERUM; LAURACEAE; RATTUS;

ADMINISTRATION, ORAL; ANIMALS; BRAIN; CINNAMOMUM ZEYLANICUM; COGNITION; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY; OXIDATIVE STRESS; PLANT BARK; PLANT EXTRACTS; RATS; RATS, WISTAR; SCOPOLAMINE HYDROBROMIDE;

EID: 84930586187     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830514Y.0000000113     Document Type: Article

References (56)

1. 1 Kurokawa M, Kumeda CA, Yamamura J, Kamiyama T, Shiraki K. Antipyretic activity of cinnamyl derivatives and related compounds in influenza virus infected mice. Eur J Pharmacol 1998; 348:45–51.
2. 2 Dhuley JN. Anti-oxidant effects of cinnamon (Cinnamomum verum) bark and greater cardamom (Amomum subulatum) seeds in rats fed high fat diet. Indian J Exp Biol 1999;37:238–42.
3. 3 Jayaprakasha GK, Kameyama MO, Ono H, Yoshida M, Rao J. Phenolic constituents in the fruits of Cinnamomum zeylanicum and their antioxidant activity. J Agric Food Chem 2006;54: 1672–9.
4. 4 Kannappan S, Jayaraman T, Rajasekar P, Ravichandran MK, Anuradha CV. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med J 2006;47:858–63.
5. 5 Dongmoa PMJ, Tatsadjieub LN, Tchoumbougnangc F, Ndongson B, Agwanande W, Sandjon B, et al. Chemical composition, antiradical and antifungal activities of essential oil of the leaves of Cinnamomum zeylanicum Blume from Cameroon. Nat Prod Commun 2007;12:1287–90.
6. 6 AL-Logmani AS, Zari TA. Effects of Nigella sativa L. and Cinnamomum zeylanicum blume oils on some physiological parameters in streptozotocin-induced diabetic rats. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 2009;8:86–96.
7. 7 Vyas N, Gavatia NP, Gupta B, Tailing M. Antidiabetic activity of alcoholic extract of Cinnamomum zeylanicum leaves in alloxon induced diabetic rats. J Pharm Res 2009;2:1867–8.
8. 8 Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003;26:3215–8.
9. 9 Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO, et al. Effects of a cinnamon extract on plasma glucose, HbA1c, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 2006;36:340–4.
10. 10 Petersona DW, Georgea RC, Scaramozzinoa F, LaPointe NE, Anderson RA, Graves DJ, et al. Cinnamon extract inhibits tau aggregation associated with Alzheimer’s disease in vitro. J Alzheimers Dis 2009;17:585–97.
11. 11 Panickar KS, Polansky MM, Anderson RA. Cinnamon polyphenols attenuate cell swelling and mitochondrial dysfunction following oxygen-glucose deprivation in glial cells. Exp Neurol 2009;216:420–7.
12. 12 Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, Flanagan VP, et al. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 2004;52:65–70.
13. 13 Tomaino A, Cimino F, Zimbalatti V, Venuti V, Sulfaro V, De Pasquale A, et al. Influence of heating on antioxidant activity and the chemical composition of some spice essential oils. Food Chem 2005;89:549–54.
14. 14 Agrawal R, Tyagi E, Saxena G, Nath C. Cholinergic influence on memory stages: a study on scopolamine amnesic mice. Indian J Pharmacol 2009;41:192–6.
15. 15 Blokland A. Scopolamine-induced deficits in cognitive performance: a review of animal studies. Scopolamine Rev 2005;1–76
16. 16 Goverdhan P, Sravanthi A, Mamatha T. Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. Int J Alzheimers Dis (Online) 2012;2012:974013, 1–8.
17. 17 Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, et al. Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett 2005;374:222–6.
18. 18 Chen J, Long Y, Han M, Wang T, Chen Q, Wang R. Watersoluble derivative of propolis mitigates scopolamine induced learning and memory impairment in mice. Pharmacol Biochem Behav 2008;90:441–6.
19. 19 El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary EES. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 2003;76: 523–33.
20. 20 Cruz R, Almaguer MW, Bergado RJA. Glutathione in cognitive function and neurodegeneration. Rev Neurol 2003; 36:877–86.
21. 21 Jeong EJ, Lee KY, Kim SH, Sung SH, Kim YC. Cognitiveenhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice. Eur J Pharmacol 2008;588:78–84.
22. 22 Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med 1997; 336:1216–22.
23. 23 Bassett CN, Montine TJ. Lipoproteins and lipid peroxidation in Alzheimer’s disease. J Nutr Health Aging 2003;7:24–9.
24. 24 Trease GE, Evans WC. A textbook of pharmacognosy, 14th ed. London: W.B. Saunder Company Ltd, 1999.
25. 25 Joshi H, Parle M. Brahmi rasayana improves learning and memory in mice. Evid Based Complement Altern Med 2006;3: 79–85.
26. 26 Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11:47–60.
27. 27 Kulkarni KS, Kasture SB, Mengi SA. Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats. Indian J Pharmacol 2010;42:168–73.
28. 28 Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979;95: 351–8.
29. 29 Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959;82:70–7.
30. 30 Yamada N, Hattori A, Hayashi T, Nishikawa T, Fukuda H, Fujino T. Improvement of scopolamine-induced memory impairment by Z-ajoene in the water maze in mice. Pharmacol Biochem Behav 2004;78:787–91.
31. 31 Yu MS, Leung SK, Lai SW, Che CM, Zee SY, So KF, et al. Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity. Exp Gerontol 2005;40:716–27.
32. 32 Wang R, Yan H, Tang XC. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol Sin 2006;27:1–26.
33. 33 Rubio J, Dang H, Gong M, Liu X, Chen SL, Gonzales GF. Aqueous and hydroalcoholic extracts of black maca (Lepidium meyenii) improve scopolamine-induced memory impairment in mice. Food Chem Toxicol 2007;45:1882–90.
34. 34 Torizuka K. Basic lecture of kampo medicine: pharmacological effect of cinnamon. Kampo Med 1998;11:431–6.
35. 35 Moselhy Said S, Ali Husein KH. Hepatoprotective effect of cinnamon extracts against carbon tetrachloride induced oxidative stress and liver injury in rats. Biol Res 2009;42:93–8.
36. 36 Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA. Effects of awater-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr 2006;28:45–53.
37. 37 Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, et al. Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in alzheimer’s disease animal models. PLoS ONE (Online) 2011;6:e16564.
38. 38 Blokland A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res 1995;21:285–300.
39. 39 Kim MJ, Choi SJ, Lim ST, Kim HK, Kim YJ, Yoon HG, et al. Zeatin supplement improves scopolamine-induced memory impairment in mice. Biosci Biotechnol Biochem 2008;72:577–81.
40. 40 Ebert U, Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 1998;28:944–9.
41. 41 Luo J, Yin JH, Wu HZ, Wei Q. Extracts from Fructus Cannabis activating calcineurin improved learning and memory in mice with chemical drug-induced dysmnesia. Acta Pharmaco Sin 2003;24:1137–42.
42. 42 Saraf MK, Prabhakar S, Khanduja KL, Anand A. Bacopa monniera attenuates scopolamine-induced impairment of spatial memory in mice. Evid Based Complement Altern Med (Online) 2011;2011:236186, 1–10.
43. 43 Forero DA, Casadesus G, Perry G, Arboleda H. Synaptic dysfunction and oxidative stress in Alzheimer’s disease, emerging mechanisms. J Cell Mol Med 2006;10:796–805.
44. 44 Ciobica A, Hritcu L, Artenie V, Padurariu M. The effects of some cholinergic drugs on cognitive processes and oxidative stress in rats. Rev Med Chir Soc Med Nat Sci 2009;113:832–7.
45. 45 Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer’s disease. J Alzheimers Dis 2009;16:741–61.
46. 46 Sekler A, Jimenez JM, Rojo L, Pastene E, Fuentes P, Slachevsky A, et al. Cognitive impairment and Alzheimer’s disease: links with oxidative stress and cholesterol metabolism. Neuropsychiatr Dis Treat 2008;4:715–22.
47. 47 Mattson MP, Pedersen WA. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer’s disease. Int J Dev Neurosci 1998;16: 626–42.
48. 48 Cimen MY. Free radical metabolism in human erythrocytes. Clin Chim Acta 2008;390:1–11.
49. 49 Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004;3:205–14.
50. 50 Perry G, Nunomura A, Siedlak SL, Harris PLR, Zhu X, Castellani RJ, et al. Oxidant and antioxidant responses in Alzheimer disease. Recent Res Dev Biophys Biochem 2001;1:35–41.
51. 51 Ohkawa H, Ohishi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–8.
52. 52 Greilberger J, Koidl C, Greilberger M, Lamprecht M, Schroecksnadel K, Leblhuber F, et al. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer’s disease. Free Radic Res 2008;42:633–8.
53. 53 Hsu CH, Chi BC, Liu MY, Li JH, Chen CJ, Chen RY. Phosphine-induced oxidative damage in rats: role of glutathione. Toxicology 2002;179:1–8.
54. 54 Bains JS, Shaw CA. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 1997;25:335–58.
55. 55 Lee KG, Shibamoto T. Determination of antioxidant potential of volatile extracts isolated from various herbs and spices. J Agric Food Chem 2002;50:4947–52.
56. 56 Lee JS, Jeon SM, Park EM, Huh TL, Kwon OS, Lee MK, et al. Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterol-fed rats. J Med Food 2003;6:183–91.